Saba Capital and affiliates hold 7,322,660 Bluerock Private Real Estate Fund common shares, representing 5.12% of the outstanding stock. The position matters because Saba Capital intends to propose terminating the Investment manager, seek board changes and conduct a proxy solicitation at the 2027 annual meeting.
Key Highlights
- Saba Capital and related parties paid approximately $107,845,238 ($107.8 million) to acquire the common shares.
- Saba Capital Management and related parties report ownership of 7,322,660 Bluerock Private Real Estate Fund common shares, equal to 5.12% of the outstanding stock.
- Saba Capital intends to seek termination of Bluerock Private Real Estate Fund’s investment manager and board changes at the 2027 annual meeting.
Bluerock Private Real Estate Fund (NYSE: BPRE) is facing a 5.12% activist position held by Saba Capital Management and related parties, representing 7,322,660 common shares. The ownership percentage is based on 143,044,372 common shares outstanding as of June 15, 2026.
$107,845,238 Invested in Common Shares
Approximately $107,845,238 ($107.8 million) was paid to acquire the reported common shares. Saba Capital Management GP, LLC serves as its general partner, while Boaz R. Weinstein is managing member of the general partner.
The plan also includes seeking board change and conducting a proxy solicitation.
FAQs
Q: What is Saba Capital’s stake in Bluerock Private Real Estate Fund?
A: Saba Capital Management and related parties report ownership of 7,322,660 Bluerock Private Real Estate Fund common shares, equal to 5.12% of the outstanding stock.
Q: What does the activist campaign mean for BPRE?
A: Saba Capital intends to seek termination of Bluerock Private Real Estate Fund’s investment manager and board changes at the 2027 annual meeting.
Q: How did Saba Capital fund its BPRE share purchases?
A: It only reports that approximately $107,845,238 was paid to acquire the reported common shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.